CUSIP: 590328100
Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
54,032,117
-
Share change
-
-1,871,486
-
Total reported value
-
$474,374,009
-
Put/Call ratio
-
85%
-
Price per share
-
$8.78
-
Number of holders
-
130
-
Value change
-
-$6,586,424
-
Number of buys
-
68
-
Number of sells
-
49
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM (MACK) as of Q3 2014
As of 30 Sep 2014,
MERRIMACK PHARMACEUTICALS IN - COM (MACK) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,032,117 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, State Street Corp, MILLENNIUM MANAGEMENT LLC, DEUTSCHE BANK AG\, Consonance Capital Management LP, NORTHERN TRUST CORP, BlackRock Institutional Trust Company, N.A., and UBS GLOBAL ASSET MANAGEMENT AMERICAS INC.
This page lists
130
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.